{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:18:55Z","timestamp":1768414735899,"version":"3.49.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery Case Reports"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijscr.2023.108456","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T18:07:55Z","timestamp":1688407675000},"page":"108456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Atypical femoral fracture in a multiple myeloma patient undergoing treatment with denosumab: A case report and literature review"],"prefix":"10.1097","volume":"108","author":[{"given":"Yasuyuki","family":"Omichi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Toki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Nishisho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Sairyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijscr.2023.108456_bb0005","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple Myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Primers."},{"issue":"8","key":"10.1016\/j.ijscr.2023.108456_bb0010","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/annonc\/mdn796","article-title":"The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European myeloma network","volume":"20","author":"Terpos","year":"2009","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.ijscr.2023.108456_bb0015","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.ijscr.2023.108456_bb0020","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2018-11-852459","article-title":"Myeloma bone disease: from biology findings to treatment approaches","volume":"133","author":"Terpos","year":"2019","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.ijscr.2023.108456_bb0025","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","article-title":"Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study","volume":"19","author":"Raje","year":"2018","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.ijscr.2023.108456_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(20)30559-3","article-title":"Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group","volume":"22","author":"Terpos","year":"2021","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.ijscr.2023.108456_bb0035","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.ijscr.2023.108456_bb0040","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1186\/s12885-019-6236-6","article-title":"Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review","volume":"19","author":"Takahashi","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ijscr.2023.108456_bb0045","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1634\/theoncologist.2016-0192","article-title":"Retrospective review of atypical femoral fracture in metastatic bone disease patients receiving denosumab therapy","volume":"22","author":"Yang","year":"2017","journal-title":"Oncologist."},{"key":"10.1016\/j.ijscr.2023.108456_bb0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijsu.2020.10.034","article-title":"The SCARE 2020 Guideline: updating consensus surgical CAse REport (SCARE) guidelines","volume":"84","author":"Agha","year":"2020","journal-title":"Int. J. Surg."},{"issue":"2","key":"10.1016\/j.ijscr.2023.108456_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11420-008-9077-4","article-title":"Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid","volume":"4","author":"Wernecke","year":"2008","journal-title":"HSS J."},{"issue":"3","key":"10.1016\/j.ijscr.2023.108456_bb0060","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.joms.2008.11.005","article-title":"Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates","volume":"67","author":"Grasko","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.ijscr.2023.108456_bb0065","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00198-009-1012-0","article-title":"Bisphosphonate-associated femoral fracture: implications for management in patients with malignancies","volume":"21","author":"Napoli","year":"2010","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ijscr.2023.108456_bb0070","doi-asserted-by":"crossref","unstructured":"Puhaindran ME, Farooki A, Steensma MR, Hameed M, Healey JH, Boland PJ. Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates. J. Bone Joint Surg. Am. 2011;93(13):1235\u201342.13.","DOI":"10.2106\/JBJS.J.01199"},{"issue":"3","key":"10.1016\/j.ijscr.2023.108456_bb0075","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11999-011-2194-2","article-title":"Femoral stress fractures associated with long-term bisphosphonate treatment","volume":"470","author":"Ward","year":"2012","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"3","key":"10.1016\/j.ijscr.2023.108456_bb0080","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bone.2012.05.010","article-title":"Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy","volume":"51","author":"Chang","year":"2012","journal-title":"Bone."},{"key":"10.1016\/j.ijscr.2023.108456_bb0085","article-title":"Bilateral atypical femoral fractures in a patient with multiple myeloma treated with intravenous bisphosphonate therapy","volume":"2014","author":"Tonogai","year":"2014","journal-title":"Case Rep Orthop."},{"issue":"3","key":"10.1016\/j.ijscr.2023.108456_bb0090","first-page":"375","article-title":"Atypical femur fracture in a woman with osteogenesis imperfecta and multiple myeloma","volume":"18","author":"Chen","year":"2018","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"8","key":"10.1016\/j.ijscr.2023.108456_bb0095","article-title":"Paradoxical stress fracture in a patient with multiple myeloma and bisphosphonate use","volume":"12","author":"Chiu","year":"2020","journal-title":"Cureus."},{"issue":"1","key":"10.1016\/j.ijscr.2023.108456_bb0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bone.2013.06.004","article-title":"Short-courses of dexamethasone abolish bisphosphonate-induced reductions in bone toughness","volume":"56","author":"Luo","year":"2013","journal-title":"Bone."},{"issue":"3","key":"10.1016\/j.ijscr.2023.108456_bb0105","first-page":"1571","article-title":"Eldecalcitol, an active vitamin D analog, effectively prevents cyclophosphamide-induced osteoporosis in rats","volume":"18","author":"Wang","year":"2019","journal-title":"Exp Ther Med."},{"issue":"2","key":"10.1016\/j.ijscr.2023.108456_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263839","article-title":"Proteasome inhibition-enhanced fracture repair in associated with increased mesenchymal progenitor cells in mice","volume":"17","author":"Zhang","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijscr.2023.108456_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"16","key":"10.1016\/j.ijscr.2023.108456_bb0120","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261223005850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261223005850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:36:08Z","timestamp":1768386968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210261223005850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":24,"alternative-id":["S2210261223005850"],"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2023.108456","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical femoral fracture in a multiple myeloma patient undergoing treatment with denosumab: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijscr.2023.108456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108456"}}